Equasens Société anonyme

Paris Stock Exchange EQS.PA

Equasens Société anonyme Free Cash Flow Per Share for the year ending December 31, 2023: USD 3.17

Equasens Société anonyme Free Cash Flow Per Share is USD 3.17 for the year ending December 31, 2023, a -4.73% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.
  • Equasens Société anonyme Free Cash Flow Per Share for the year ending December 31, 2022 was USD 3.33, a 18.37% change year over year.
  • Equasens Société anonyme Free Cash Flow Per Share for the year ending December 31, 2021 was USD 2.81, a 25.95% change year over year.
  • Equasens Société anonyme Free Cash Flow Per Share for the year ending December 31, 2020 was USD 2.23, a 26.32% change year over year.
  • Equasens Société anonyme Free Cash Flow Per Share for the year ending December 31, 2019 was USD 1.77, a 30.79% change year over year.
Key data
Date Free Cash Flow Per Share Return on Assets (ROA) Return on Equity (ROE) Return on Capital Employed (ROCE)
Market news
Loading...
Paris Stock Exchange: EQS.PA

Equasens Société anonyme

CEO Mr. Grégoire De Rotalier
IPO Date Oct. 25, 2000
Location France
Headquarters 5 AllEe de Saint Cloud
Employees 1,271
Sector Health Care
Industries
Description

Equasens Société anonyme provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists' business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services. In addition, it offers a ULTIMATE, a system combining optimized pharmacy management and improved patient support; FARMACLICK, a protocol for communications between pharmacies and wholesalers-distributors; DIFARM, a solution for wholesalers-distributors; PHARE, a retail management tool; SOPHIA, a pharmacy management application; OffiMédia POS display; eNephro to enhance the care of chronic renal failure patients; and TPE Pilot, a web-based application that simplifies the management and sharing of patient education programs. Further, the company provides NOVIACARE; CARELIB Domicile; CARELIB EHPAD; KAPELSE solutions; TITAN solutions; ANTHADINE software and MOBISOINS mobile tool; MICROSOINS, an in-home nursing care solution; and LOGICLIC. Additionally, it offers AXIGATE solutions to manage the entire patient care pathway; CHORUS platform; medical telesecretarial services for healthcare professionals; and equipment lease financing solutions. The company was incorporated in 1996 and is based in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.

Similar companies

THEP.PA

Thermador Groupe SA

USD 71.11

3.30%

GTT.PA

Gaztransport & Technigaz SA

USD 143.25

0.03%

VETO.PA

Vetoquinol SA

USD 71.52

-1.80%

TEP.PA

Teleperformance SE

USD 86.24

2.42%

RBT.PA

Robertet SA

USD 865.71

0.60%

StockViz Staff

January 15, 2025

Any question? Send us an email